Results 91 to 100 of about 1,968,036 (106)

The incidence of anti-HMGCR immune-mediated necrotizing myopathy: an Australian and UK retrospective multi-site cohort study

open access: yes
Objectives Immune-mediated necrotizing myopathy (IMNM) with autoantibodies targeting 3-hydroxy-3-methylglutaryl-CoA reductase (anti-HMGCR) is considered a rare complication of statin therapy.
Brusch, Anna   +13 more
core  

Alanine transaminase is predominantly increased in the active phase of anti-HMGCR myopathy

Neuromuscular Disorders, 2022
Ran Nakashima   +2 more
exaly  

Necrotizing myopathy with elevated anti-HMGCR antibodies following exposure to the supplement Bacopa

Muscle and Nerve, 2023
Maxwell Greene   +2 more
exaly  

Anti-HMGCR Antibody-Positive Myopathy Shows Bcl-2-Positive Inflammation and Lymphocytic Accumulations

Journal of Neuropathology and Experimental Neurology, 2020
Tetsuya Takahashi   +2 more
exaly  

Anti-HMGCR myopathy following acute Epstein–Barr virus infection

Muscle and Nerve, 2020
Ichizo Nishino   +2 more
exaly  

Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China

Journal of Clinical Neuroscience, 2018
Wen-Hua Zhu, Chong-Bo Zhao
exaly  

Home - About - Disclaimer - Privacy